UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018872
Receipt number R000021817
Scientific Title The effect of walking training by using anti-gravity tredmil after total knee arthroplasty
Date of disclosure of the study information 2015/09/05
Last modified on 2023/03/08 09:28:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of walking training by using anti-gravity tredmil after total knee arthroplasty

Acronym

The effect of anti-gravity tredmil after TKA

Scientific Title

The effect of walking training by using anti-gravity tredmil after total knee arthroplasty

Scientific Title:Acronym

The effect of anti-gravity tredmil after TKA

Region

Japan


Condition

Condition

Knee osteoarthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of walking training by anti-gravity tredmil after total knee arthroplasty by using 3-dimentional walking evaluation system

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

walking kinematics
(preoperation, p.o 2-3 weeks, p.o. 6-7 weeks)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Walking training by using anti-gravity tredmil
30-60 minutes for each training
3 times (preoperation, p.o. 2-3 weeks, p.o. 6-7 weeks)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Female

Key inclusion criteria

1. Total knee arthroplasty will be performed for primary OA
2. Patient has given consent to participate in the study.
3. Rehabilitation will be able to start a week after operation.
4. less than 80 years old

Key exclusion criteria

1. Patient is immunosuppressed or has an autoimmune immunodeficient disorder.
2. Patient has an autoimmune disorder.
3. Patient has had major, non-arthroscopic surgery to the study knee.
4. Patient has an active, local infection or systemic infection.
5. Patient has a physical, emotional or neurological condition that would compromise compliance with postoperative rehabilitation and follow up.
6. Patient has pacemaker or possibility to have a trouble by using Bluetooth sensor.
7. Patient has hip inflammatory arthritis or performed THA.
8. Patient is pregnant or plans to pregnant during course of study.
9. Patient is on workman's compensation.
10. Serious medical infirmity.
11. Symptomatic spinal disease.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Harukazu
Middle name
Last name Tohyama

Organization

Hokkaido University, Sapporo, Japan

Division name

Department of Rehabilitation

Zip code

060-8648

Address

Kita 14, Nishi 5, Kita-ku, Sapporo

TEL

011-706-3393

Email

tohyama@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Tomohiro
Middle name
Last name Onodera

Organization

Hokkaido University, Sapporo, Japan

Division name

Department of Orthopaedic Surgery

Zip code

060-8648

Address

Kita 14, Nishi 5, Kita-ku, Sapporo

TEL

011-706-5935

Homepage URL


Email

tomozou@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University, Sapporo, Japan

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University, Sapporo, Japan

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University

Address

Kita 14, Nishi 5

Tel

0117065935

Email

tomozou@med.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 09 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 08 Month 24 Day

Date of IRB

2015 Year 09 Month 24 Day

Anticipated trial start date

2015 Year 10 Month 01 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 09 Month 01 Day

Last modified on

2023 Year 03 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021817


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name